The millennium bugs — the need for and development of new antibacterials
- 1 September 2000
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (1) , 51-59
- https://doi.org/10.1016/s0924-8579(00)00189-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compoundsDiagnostic Microbiology and Infectious Disease, 1999
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- HMR-3647Drugs of the Future, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- The Effect of Changes in the Consumption of Macrolide Antibiotics on Erythromycin Resistance in Group A Streptococci in FinlandNew England Journal of Medicine, 1997
- The future—can we learn from the past?Diagnostic Microbiology and Infectious Disease, 1997
- Antibiotic Resistance: A View from the Pharmaceutical IndustryClinical Infectious Diseases, 1997
- Antimicrobial-Drug ResistanceNew England Journal of Medicine, 1996
- Growth in the use of antibiotics in the community in England and Scotland in 1980-93BMJ, 1996
- Decline of erythromycin resistance of Group A streptococci in JapanThe Pediatric Infectious Disease Journal, 1994